Sudden cardiac death in postmyocardial-infarction patients

J Fahed1, K C Floyd, D A Tighe

  • 1Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA - dennis.tighe@umassmemorial.org.

Panminerva Medica
|February 12, 2015
PubMed

Insights

Patients surviving myocardial infarction face high risk of sudden cardiac death due to ventricular arrhythmias. This review covers risk factors, prevention strategies, and treatments like implantable cardioverter-defibrillators for this high-risk population.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Preventive Medicine

Background:

  • Patients surviving myocardial infarction (MI) have an elevated risk of sudden cardiac death (SCD).
  • Ventricular arrhythmias are the primary cause of SCD in the post-MI population.
  • Effective risk stratification and prevention strategies are crucial for improving outcomes.

Purpose of the Study:

  • To review the epidemiology of sudden cardiac death in post-MI patients.
  • To explore arrhythmia mechanisms and risk factors for SCD.
  • To discuss risk stratification, evidence-based therapies, and the role of implantable cardioverter-defibrillators (ICDs).

Main Methods:

  • Literature review of epidemiological data.
  • Analysis of arrhythmia mechanisms and substrate.
  • Evaluation of major clinical trials and therapeutic interventions.
  • Assessment of current guideline recommendations.

Main Results:

  • Identified key risk factors for SCD in post-MI patients.
  • Summarized evidence supporting various preventive strategies.
  • Highlighted the efficacy of implantable cardioverter-defibrillators in selected high-risk individuals.
  • Outlined current therapeutic approaches and guideline recommendations.

Conclusions:

  • Sudden cardiac death remains a significant concern for post-MI survivors.
  • Risk stratification and timely intervention are essential for SCD prevention.
  • Implantable cardioverter-defibrillators play a vital role in managing high-risk patients.
  • Ongoing research and guideline updates are critical for optimizing care.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
592
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
543
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
803
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
499